<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The release of insufficient amounts of insulin in the presence of elevated blood <z:chebi fb="105" ids="17234">glucose</z:chebi> levels is one of the key features of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Various lines of evidence indicate that <z:chebi fb="9" ids="15355">acetylcholine</z:chebi> (<z:chebi fb="0" ids="15355">ACh</z:chebi>), the major neurotransmitter of the parasympathetic <z:mp ids='MP_0008912'>nervous</z:mp> system, can enhance <z:chebi fb="105" ids="17234">glucose</z:chebi>-stimulated insulin secretion from pancreatic beta-cells </plain></SENT>
<SENT sid="2" pm="."><plain>Studies with isolated islets prepared from whole body M(3) muscarinic <z:chebi fb="0" ids="15355">ACh</z:chebi> receptor knockout mice showed that cholinergic amplification of <z:chebi fb="105" ids="17234">glucose</z:chebi>-dependent insulin secretion is exclusively mediated by the M(3) muscarinic receptor subtype </plain></SENT>
<SENT sid="3" pm="."><plain>To investigate the physiological relevance of this muscarinic pathway, we used Cre/loxP technology to generate mutant mice that lack M(3) receptors only in pancreatic beta-cells </plain></SENT>
<SENT sid="4" pm="."><plain>These mutant mice displayed <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> and significantly <z:mp ids='MP_0003059'>reduced insulin secretion</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast, transgenic mice overexpressing M(3) receptors in pancreatic beta-cells showed a pronounced increase in <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance and insulin secretion and were resistant to diet-induced <z:hpo ids='HP_0000833'>glucose intolerance</z:hpo> and <z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">hyperglycaemia</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>These findings indicate that beta-cell M(3) muscarinic receptors are essential for maintaining proper insulin secretion and <z:chebi fb="105" ids="17234">glucose</z:chebi> homeostasis </plain></SENT>
<SENT sid="7" pm="."><plain>Moreover, our data suggest that enhancing signalling through beta-cell M(3) muscarinic receptors may represent a new avenue in the treatment of <z:hpo ids='HP_0000833'>glucose intolerance</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>